Wasatch Advisors Inc Medpace Holdings, Inc. Transaction History

Wasatch Advisors Inc

  • $17.6 Billion
  • Q1 2025

A detailed history of Wasatch Advisors Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 829,460 shares of MEDP stock, worth $250 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
829,460
Previous 936,842 11.46%
Holding current value
$250 Million
Previous $311 Million 18.8%
% of portfolio
1.43%
Previous 1.56%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$304.69 - $360.97 $32.7 Million - $38.8 Million
-107,382 Reduced 11.46%
829,460 $253 Million
Q4 2024

Feb 13, 2025
BUY
$308.93 - $363.58 $8.7 Million - $10.2 Million
28,161 Added 3.1%
936,842 $311 Million
Q3 2024

Nov 14, 2024
SELL
$320.58 - $457.29 $18.8 Million - $26.8 Million
-58,602 Reduced 6.06%
908,681 $303 Million
Q2 2024

Aug 14, 2024
SELL
$372.0 - $424.34 $2.65 Million - $3.03 Million
-7,132 Reduced 0.73%
967,283 $398 Million
Q1 2024

Apr 18, 2024
SELL
$284.87 - $413.31 $60.3 Million - $87.5 Million
-211,766 Reduced 17.85%
974,415 $394 Million
Q4 2023

Feb 14, 2024
SELL
$227.52 - $312.68 $19.5 Million - $26.8 Million
-85,655 Reduced 6.73%
1,186,181 $364 Million
Q3 2023

Nov 14, 2023
SELL
$233.98 - $281.67 $69.5 Million - $83.7 Million
-297,065 Reduced 18.93%
1,271,836 $308 Million
Q2 2023

Aug 07, 2023
SELL
$187.26 - $240.17 $54.3 Million - $69.6 Million
-289,753 Reduced 15.59%
1,568,901 $377 Million
Q1 2023

May 12, 2023
BUY
$174.31 - $239.52 $38.5 Million - $52.9 Million
220,836 Added 13.48%
1,858,654 $350 Million
Q4 2022

Feb 14, 2023
SELL
$153.06 - $226.57 $79.2 Million - $117 Million
-517,688 Reduced 24.02%
1,637,818 $348 Million
Q3 2022

Nov 14, 2022
SELL
$145.13 - $182.49 $31.6 Million - $39.7 Million
-217,717 Reduced 9.17%
2,155,506 $339 Million
Q2 2022

Aug 12, 2022
SELL
$130.2 - $168.03 $46.2 Million - $59.7 Million
-355,169 Reduced 13.02%
2,373,223 $355 Million
Q1 2022

May 13, 2022
BUY
$138.87 - $214.31 $40.8 Million - $63 Million
294,103 Added 12.08%
2,728,392 $446 Million
Q4 2021

Feb 15, 2022
SELL
$182.74 - $227.9 $11.3 Million - $14.1 Million
-61,773 Reduced 2.47%
2,434,289 $530 Million
Q3 2021

Nov 12, 2021
BUY
$170.18 - $198.21 $7.96 Million - $9.27 Million
46,770 Added 1.91%
2,496,062 $472 Million
Q2 2021

Aug 12, 2021
SELL
$158.62 - $194.3 $32.5 Million - $39.8 Million
-204,694 Reduced 7.71%
2,449,292 $433 Million
Q1 2021

May 10, 2021
SELL
$132.02 - $168.26 $24.7 Million - $31.5 Million
-187,008 Reduced 6.58%
2,653,986 $435 Million
Q4 2020

Feb 12, 2021
BUY
$109.38 - $149.19 $62.4 Million - $85.1 Million
570,266 Added 25.11%
2,840,994 $395 Million
Q3 2020

Nov 10, 2020
SELL
$92.95 - $130.61 $27 Million - $37.9 Million
-290,275 Reduced 11.33%
2,270,728 $254 Million
Q2 2020

Aug 12, 2020
BUY
$68.08 - $95.68 $18.4 Million - $25.9 Million
270,621 Added 11.82%
2,561,003 $238 Million
Q1 2020

May 08, 2020
BUY
$61.71 - $101.95 $30 Million - $49.5 Million
485,397 Added 26.89%
2,290,382 $168 Million
Q4 2019

Feb 13, 2020
BUY
$70.08 - $84.64 $27.9 Million - $33.8 Million
398,775 Added 28.36%
1,804,985 $152 Million
Q3 2019

Nov 14, 2019
SELL
$62.38 - $85.89 $37.4 Million - $51.4 Million
-598,917 Reduced 29.87%
1,406,210 $118 Million
Q2 2019

Aug 07, 2019
BUY
$53.64 - $65.42 $32.2 Million - $39.3 Million
600,686 Added 42.77%
2,005,127 $0
Q1 2019

May 08, 2019
BUY
$49.38 - $70.58 $10.3 Million - $14.8 Million
209,449 Added 17.53%
1,404,441 $0
Q4 2018

Feb 14, 2019
BUY
$46.97 - $63.98 $56.1 Million - $76.5 Million
1,194,992 New
1,194,992 $63.3 Million

Others Institutions Holding MEDP

# of Institutions
626
Shares Held
26M
Call Options Held
46.4K
Put Options Held
80.8K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.36B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email